vs
Side-by-side financial comparison of BankUnited, Inc. (BKU) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $288.2M, roughly 1.2× BankUnited, Inc.). On growth, BankUnited, Inc. posted the faster year-over-year revenue change (9.0% vs 2.2%).
BankUnited, Inc. is the bank holding company of BankUnited, N.A., a national bank founded in 1984 and headquartered in Miami Lakes, Florida. The company operates in Florida; the regions in and around Atlanta, Georgia; Dallas, Texas; Morristown, New Jersey; Charlotte, North Carolina; and in the New York metropolitan area. BankUnited also offers certain commercial lending and deposit products through national platforms and has total assets of $35.0 billion as of December 31, 2025
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
BKU vs GRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $288.2M | $336.6M |
| Net Profit | — | $13.5M |
| Gross Margin | — | 22.7% |
| Operating Margin | 31.2% | 5.3% |
| Net Margin | — | 4.0% |
| Revenue YoY | 9.0% | 2.2% |
| Net Profit YoY | — | 46.1% |
| EPS (diluted) | $0.89 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.6M | ||
| Q4 25 | $288.2M | $397.6M | ||
| Q3 25 | $275.7M | $377.4M | ||
| Q2 25 | $273.9M | $344.3M | ||
| Q1 25 | $255.4M | $329.3M | ||
| Q4 24 | $264.5M | — | ||
| Q3 24 | $257.0M | $314.4M | ||
| Q2 24 | $250.2M | — |
| Q1 26 | — | $13.5M | ||
| Q4 25 | — | $20.9M | ||
| Q3 25 | $71.9M | $9.8M | ||
| Q2 25 | $68.8M | $9.0M | ||
| Q1 25 | $58.5M | $9.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.5M | $-122.0M | ||
| Q2 24 | $53.7M | — |
| Q1 26 | — | 22.7% | ||
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 19.4% | ||
| Q2 24 | — | — |
| Q1 26 | — | 5.3% | ||
| Q4 25 | 31.2% | 7.7% | ||
| Q3 25 | 35.5% | 4.3% | ||
| Q2 25 | 34.3% | 3.7% | ||
| Q1 25 | 31.4% | 3.9% | ||
| Q4 24 | 35.2% | — | ||
| Q3 24 | 32.4% | -33.3% | ||
| Q2 24 | 29.2% | — |
| Q1 26 | — | 4.0% | ||
| Q4 25 | — | 5.3% | ||
| Q3 25 | 26.1% | 2.6% | ||
| Q2 25 | 25.1% | 2.6% | ||
| Q1 25 | 22.9% | 2.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | 23.9% | -38.8% | ||
| Q2 24 | 21.5% | — |
| Q1 26 | — | $0.21 | ||
| Q4 25 | $0.89 | — | ||
| Q3 25 | $0.95 | — | ||
| Q2 25 | $0.91 | — | ||
| Q1 25 | $0.78 | — | ||
| Q4 24 | $0.91 | — | ||
| Q3 24 | $0.81 | — | ||
| Q2 24 | $0.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $217.8M | $64.9M |
| Total DebtLower is stronger | $319.7M | — |
| Stockholders' EquityBook value | $3.1B | $232.4M |
| Total Assets | $35.0B | $426.9M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.9M | ||
| Q4 25 | $217.8M | $65.6M | ||
| Q3 25 | $559.5M | $36.5M | ||
| Q2 25 | $801.3M | $18.8M | ||
| Q1 25 | $443.7M | $14.0M | ||
| Q4 24 | $491.1M | — | ||
| Q3 24 | $889.9M | $37.2M | ||
| Q2 24 | $433.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $319.7M | $0 | ||
| Q3 25 | $320.4M | — | ||
| Q2 25 | $708.9M | — | ||
| Q1 25 | $709.1M | — | ||
| Q4 24 | $708.6M | — | ||
| Q3 24 | $708.7M | $34.3M | ||
| Q2 24 | $708.8M | — |
| Q1 26 | — | $232.4M | ||
| Q4 25 | $3.1B | $217.9M | ||
| Q3 25 | $3.0B | $195.5M | ||
| Q2 25 | $3.0B | $179.7M | ||
| Q1 25 | $2.9B | $163.2M | ||
| Q4 24 | $2.8B | — | ||
| Q3 24 | $2.8B | $133.9M | ||
| Q2 24 | $2.7B | — |
| Q1 26 | — | $426.9M | ||
| Q4 25 | $35.0B | $412.7M | ||
| Q3 25 | $35.1B | $390.0M | ||
| Q2 25 | $35.5B | $356.3M | ||
| Q1 25 | $34.8B | $334.0M | ||
| Q4 24 | $35.2B | — | ||
| Q3 24 | $35.8B | $348.0M | ||
| Q2 24 | $35.4B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.10× | 0.00× | ||
| Q3 25 | 0.11× | — | ||
| Q2 25 | 0.24× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | 0.25× | 0.26× | ||
| Q2 24 | 0.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $358.6M | $6.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | $358.6M | $34.6M | ||
| Q3 25 | $99.7M | $28.2M | ||
| Q2 25 | $117.6M | $19.9M | ||
| Q1 25 | $16.4M | $17.6M | ||
| Q4 24 | $433.8M | — | ||
| Q3 24 | $46.1M | — | ||
| Q2 24 | $135.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $24.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | 1.65× | ||
| Q3 25 | 1.39× | 2.87× | ||
| Q2 25 | 1.71× | 2.21× | ||
| Q1 25 | 0.28× | 1.86× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.75× | — | ||
| Q2 24 | 2.53× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
